BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 29464587)

  • 1. Comparison of the Effects of Vonoprazan and Lansoprazole for Treating Endoscopic Submucosal Dissection-Induced Artificial Ulcers.
    Hirai A; Takeuchi T; Takahashi Y; Kawaguchi S; Ota K; Harada S; Kojima Y; Tominaga K; Tokioka S; Higuchi K
    Dig Dis Sci; 2018 Apr; 63(4):974-981. PubMed ID: 29464587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of vonoprazan on the treatment of artificial gastric ulcers after endoscopic submucosal dissection: Prospective randomized controlled trial.
    Tsuchiya I; Kato Y; Tanida E; Masui Y; Kato S; Nakajima A; Izumi M
    Dig Endosc; 2017 Jul; 29(5):576-583. PubMed ID: 28267236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vonoprazan is superior to proton pump inhibitors in healing artificial ulcers of the stomach post-endoscopic submucosal dissection: A propensity score-matching analysis.
    Maruoka D; Arai M; Kasamatsu S; Ishigami H; Taida T; Okimoto K; Saito K; Matsumura T; Nakagawa T; Katsuno T; Yokosuka O
    Dig Endosc; 2017 Jan; 29(1):57-64. PubMed ID: 27492962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vonoprazan prevents bleeding from endoscopic submucosal dissection-induced gastric ulcers.
    Kagawa T; Iwamuro M; Ishikawa S; Ishida M; Kuraoka S; Sasaki K; Sakakihara I; Izumikawa K; Yamamoto K; Takahashi S; Tanaka S; Matsuura M; Hasui T; Wato M; Inaba T
    Aliment Pharmacol Ther; 2016 Sep; 44(6):583-91. PubMed ID: 27464849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A prospective randomized trial of a potassium competitive acid blocker vs proton pump inhibitors on the effect of ulcer healing after endoscopic submucosal dissection of gastric neoplasia.
    Komori H; Ueyama H; Nagahara A; Akazawa Y; Takeda T; Matsumoto K; Matsumoto K; Asaoka D; Hojo M; Yao T; Watanabe S
    J Int Med Res; 2019 Apr; 47(4):1441-1452. PubMed ID: 30816056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Short-term efficacy of potassium-competitive acid blocker following gastric endoscopic submucosal dissection: a propensity score analysis.
    Horikawa Y; Mizutamari H; Mimori N; Kato Y; Fushimi S; Sato S; Okubo S
    Scand J Gastroenterol; 2018 Feb; 53(2):243-251. PubMed ID: 29214885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of vonoprazan in prevention of bleeding from endoscopic submucosal dissection-induced gastric ulcers: a prospective randomized phase II study.
    Hamada K; Uedo N; Tonai Y; Arao M; Suzuki S; Iwatsubo T; Kato M; Shichijo S; Yamasaki Y; Matsuura N; Nakahira H; Kanesaka T; Yamamoto S; Akasaka T; Hanaoka N; Takeuchi Y; Higashino K; Ishihara R; Okada H; Iishi H; Fukui K; Shimokawa T
    J Gastroenterol; 2019 Feb; 54(2):122-130. PubMed ID: 29943163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vonoprazan is Superior to Rabeprazole for Healing Endoscopic Submucosal Dissection: Induced Ulcers.
    Yamasaki A; Yoshio T; Muramatsu Y; Horiuchi Y; Ishiyama A; Hirasawa T; Tsuchida T; Sasaki Y; Fujisaki J
    Digestion; 2018; 97(2):170-176. PubMed ID: 29310111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vonoprazan versus lansoprazole in the treatment of artificial gastric ulcers after endoscopic submucossal dissection: a randomized, open-label trial.
    Kawai D; Takenaka R; Ishiguro M; Okanoue S; Gotoda T; Kono Y; Takemoto K; Tsugeno H; Fujiki S
    BMC Gastroenterol; 2021 May; 21(1):236. PubMed ID: 34022796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized Controlled Trial Comparing the Effects of Vonoprazan Plus Rebamipide and Esomeprazole Plus Rebamipide on Gastric Ulcer Healing Induced by Endoscopic Submucosal Dissection.
    Ichida T; Ueyama S; Eto T; Kusano F; Sakai Y
    Intern Med; 2019 Jan; 58(2):159-166. PubMed ID: 30210115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The efficacy of vonoprazan for management of post-endoscopic submucosal dissection ulcers compared with proton pump inhibitors: A meta-analysis.
    Liu C; Feng BC; Zhang Y; Li LX; Zuo XL; Li YQ
    J Dig Dis; 2019 Oct; 20(10):503-511. PubMed ID: 31414725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vonoprazan versus proton-pump inhibitors for gastric endoscopic submucosal dissection-induced ulcers: a systematic review and meta-analysis.
    Jaruvongvanich V; Poonsombudlert K; Ungprasert P
    Eur J Gastroenterol Hepatol; 2018 Dec; 30(12):1416-1421. PubMed ID: 29985791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vonoprazan versus proton pump inhibitors for the management of gastric endoscopic submucosal dissection-induced artificial ulcer: A systematic review with meta-analysis.
    Kang H; Kim BJ; Choi G; Kim JG
    Medicine (Baltimore); 2019 Jun; 98(24):e15860. PubMed ID: 31192917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vonoprazan versus proton pump inhibitors in treating post-endoscopic submucosal dissection ulcers and preventing bleeding: Protocol for meta-analysis of randomized controlled trials and observational studies.
    Martin ; Zhou Y; Meng CX; Takagi T; Tian YS
    Medicine (Baltimore); 2019 Feb; 98(8):e14381. PubMed ID: 30813139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vonoprazan vs proton pump inhibitors in treating post-endoscopic submucosal dissection ulcers and preventing bleeding: A meta-analysis of randomized controlled trials and observational studies.
    Martin ; Zhou Y; Meng CX; Takagi T; Tian YS
    Medicine (Baltimore); 2020 Feb; 99(9):e19357. PubMed ID: 32118778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk Factors for Delayed Ulcer Healing after Endoscopic Submucosal Dissection of Gastric Neoplasms.
    Shimozato A; Sasaki M; Ogasawara N; Funaki Y; Ebi M; Tamura Y; Izawa S; Hijikata Y; Yamaguchi Y; Kasugai K
    J Gastrointestin Liver Dis; 2017 Dec; 26(4):363-368. PubMed ID: 29253050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Outcomes of Vonoprazan-Treated Patients after Endoscopic Submucosal Dissection for Gastric Neoplasms: A Prospective Multicenter Observation Study.
    Ishida T; Dohi O; Yamada S; Yasuda T; Yamada N; Tomie A; Tsuji T; Horii Y; Majima A; Horie R; Fukui A; Zen K; Tomatsuri N; Yagi N; Naito Y; Itoh Y
    Digestion; 2021; 102(3):386-396. PubMed ID: 32585678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative efficacy of various anti-ulcer medications after gastric endoscopic submucosal dissection: a systematic review and network meta-analysis.
    Kim EH; Park SW; Nam E; Lee JG; Park CH
    Surg Endosc; 2019 Apr; 33(4):1271-1283. PubMed ID: 30167955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vonoprazan vs. Lansoprazole for the treatment of endoscopic submucosal dissection induced gastric ulcer: a systematic review and meta-analysis.
    Miao T; Zhang Y; Bai L; Yang X; Wen X
    Rev Esp Enferm Dig; 2023 Apr; 115(4):168-174. PubMed ID: 35899702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the efficacy of 4- and 8-week lansoprazole treatment for ESD-induced gastric ulcers: a randomized, prospective, controlled study.
    Park JH; Baek EK; Choi CH; Lee KH; Kim BJ; Kim JW; Kim JG; Chang SK
    Surg Endosc; 2014 Jan; 28(1):235-41. PubMed ID: 23996340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.